|
|
Article: Other News To Note.
- Article from:
- BIOWORLD Today
- Article date:
- November 4, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Antex Biologics Inc., of Gaithersburg, Md., said it plans to report later this week at the annual meeting of the American Society of Microbiologists in Salt Lake City on immunogenicity and protective efficacy results obtained from a family of nine proteins encoded by the intracellular pathogen Chlamydia trachomatis. The company will report that a team of Antex scientists found that recombinant forms of polymorphic membranes are highly conserved among different Chlamydia serovars, protect animals against Chlamydia-induced infertility and confer heterotypic cross-protection. Antex said it hopes to initiate a Phase I trial of its Tracvax recombinant subunit vaccine against ...